Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical TMB-001 for Congenital Ichthyosis
NCT04154293Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TMB-001 in congenital ichthyosis, sponsored by LEO Pharma. Started Dec 2019; status: completed.
02
Drugs
TMB-001
03
Conditions
congenital ichthyosis
Beyond the preview
Go deeper on NCT04154293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04154293.